CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in LYEL — Lyell Immunopharma, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in LYEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,511,358
-$213,220 QoQ
Shares Held
107,570
+25.1% QoQ
Ownership
0.439%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 87 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LYEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. LYEL ranks #204 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in LYEL
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,511,358 | 107,570 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,724,578 | 85,971 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,629,319 | 85,423 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,291,242 | 79,510 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $543,686 | 61,503 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $863,315 | 1,604,676 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $1,053,303 | 1,645,787 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $1,583,370 | 1,147,370 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,881,580 | 1,297,642 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,853,088 | 1,279,412 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,457,714 | 1,266,863 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,838,545 | 1,250,711 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $3,663,388 | 1,152,009 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $2,689,158 | 1,139,474 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,931,010 | 1,132,856 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $8,151,766 | 1,112,110 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,189,629 | 489,207 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,288,377 | 453,144 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,325,134 | 171,206 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,460,574 | 166,255 | Shares | Sole | 2021-11-16 | |
| No filing history on record for this holder in this stock. | ||||||